Announcement on Company Re-certified as High-tech Enterprise
Filed with SSE · · 1 page · Chinese
Hainan Huluwa Pharmaceutical Group Co. Ltd. on 6ix
Earlier from Hainan Huluwa Pharmaceutical
- Announcement on Progress in Implementing Other Risk Warnings for the Company's Stocks
- Announcement on Obtaining Drug Registration Certificate
- Announcement on Wholly-owned Subsidiary Obtaining Drug Registration Certificate for Ambroxol Hydrochloride Oral Drops
- Announcement on Progress in Judicial Auction of Some Shares Held by Controlling Shareholder
- Announcement on Obtaining the Drug Registration Certificate for Ipratropium Bromide Solution for Inhalation
Later from Hainan Huluwa Pharmaceutical
- Announcement on Freezing of Some Shares of Controlling Shareholder
- Announcement on Confirming Remunerations for Directors and Senior Management Members in 2025 and 2026 Remuneration Plan
- Indicative Announcement on the Completion of Judicial Auction and Transfer of Some Shares Held by Controlling Shareholder and Equity Change
- Indicative Announcement on the Company Being Subject to Compulsory Enforcement
- Announcement on Proposed Inclusion of Company Drugs in the Centralized Volume Procurement of National Chinese Patent Medicine Procurement Alliance (4th Round)
Follow Hainan Huluwa Pharmaceutical into a list and get an email when it puts out news.
Follow Hainan Huluwa Pharmaceutical